161 related articles for article (PubMed ID: 3284636)
1. The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling.
Nagashima T; Hoshino T; Cho KG; Edwards MS; Hudgins RJ; Davis RL
Cancer; 1988 Jun; 61(12):2433-8. PubMed ID: 3284636
[TBL] [Abstract][Full Text] [Related]
2. Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index.
Asai A; Hoshino T; Edwards MS; Davis RL
Childs Nerv Syst; 1992 Aug; 8(5):273-8. PubMed ID: 1394266
[TBL] [Abstract][Full Text] [Related]
3. The proliferative activity of neurilemomas.
Lee KS; Nagashima T; Cho KG; Mampalam TJ; Pitts LH; Hoshino T
Surg Neurol; 1989 Dec; 32(6):427-33. PubMed ID: 2700052
[TBL] [Abstract][Full Text] [Related]
4. [A cell kinetic study of human central nervous system tumors with 5-bromodeoxyuridine (BrdU)].
Nagashima T; Hoshino T
No To Shinkei; 1985 Dec; 37(12):1195-201. PubMed ID: 3912000
[TBL] [Abstract][Full Text] [Related]
5. Proliferative potential of vascular components in human glioblastoma multiforme.
Nagashima T; Hoshino T; Cho KG
Acta Neuropathol; 1987; 73(3):301-5. PubMed ID: 3039783
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases.
Prayson RA
Am J Clin Pathol; 1998 Nov; 110(5):629-34. PubMed ID: 9802348
[TBL] [Abstract][Full Text] [Related]
7. Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine.
Hoshino T; Nagashima T; Murovic JA; Wilson CB; Davis RL
Cancer; 1986 Oct; 58(7):1466-72. PubMed ID: 2427189
[TBL] [Abstract][Full Text] [Related]
8. [Cerebrospinal fluid spread of ependymomas].
de Tribolet N; Déruaz JP; Zander E
Schweiz Arch Neurol Neurochir Psychiatr; 1978; 123(1):83-91. PubMed ID: 734375
[TBL] [Abstract][Full Text] [Related]
9. Epithelial differentiation and proliferative potential in spinal ependymomas.
Takeuchi H; Kubota T; Sato K; Llena JF; Hirano A
J Neurooncol; 2002 May; 58(1):13-9. PubMed ID: 12160136
[TBL] [Abstract][Full Text] [Related]
10. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
[TBL] [Abstract][Full Text] [Related]
11. Spinal intramedullary ependymomas: surgical results and immunohistochemical analysis of tumour proliferation activity.
Iwasaki Y; Hida K; Sawamura Y; Abe H
Br J Neurosurg; 2000 Aug; 14(4):331-6. PubMed ID: 11045198
[TBL] [Abstract][Full Text] [Related]
12. Spinal ependymomas. Part 2: Ependymomas of the filum terminale.
Klekamp J
Neurosurg Focus; 2015 Aug; 39(2):E7. PubMed ID: 26235024
[TBL] [Abstract][Full Text] [Related]
13. The growth potential of ependymomas with varying grades of malignancy measured by the Ki-67 labelling index and mitotic index.
Schröder R; Ploner C; Ernestus RI
Neurosurg Rev; 1993; 16(2):145-50. PubMed ID: 8345908
[TBL] [Abstract][Full Text] [Related]
14. Cytologic diagnosis of spinal cord ependymoma in cerebrospinal fluid.
Kalogeraki A; Tamiolakis D; Sinatkas V; Xekalou A; Papadakis M; Stathopoulos EN
Pathologica; 2012 Dec; 104(6):425-7. PubMed ID: 23547427
[TBL] [Abstract][Full Text] [Related]
15. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
Hoshino T; Nagashima T; Murovic JA; Wilson CB; Edwards MS; Gutin PH; Davis RL; DeArmond SJ
J Neurosurg; 1986 Mar; 64(3):453-9. PubMed ID: 3950723
[TBL] [Abstract][Full Text] [Related]
16. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in intracranial ependymomas in children.
Figarella-Branger D; Civatte M; Bouvier-Labit C; Gouvernet J; Gambarelli D; Gentet JC; Lena G; Choux M; Pellissier JF
J Neurosurg; 2000 Oct; 93(4):605-13. PubMed ID: 11014538
[TBL] [Abstract][Full Text] [Related]
18. Determination of proliferative activities in human brain tumor specimens: a comparison of three methods.
Morimura T; Kitz K; Stein H; Budka H
J Neurooncol; 1991 Feb; 10(1):1-11. PubMed ID: 2022970
[TBL] [Abstract][Full Text] [Related]
19. In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.
Morimura T; Kitz K; Budka H
Acta Neuropathol; 1989; 77(3):276-82. PubMed ID: 2922990
[TBL] [Abstract][Full Text] [Related]
20. Pediatric central nervous system tumors: a cell kinetic study with bromodeoxyuridine.
Murovic JA; Nagashima T; Hoshino T; Edwards MS; Davis RL
Neurosurgery; 1986 Dec; 19(6):900-4. PubMed ID: 3027608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]